Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Trudeau

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
BMJ Open|June 4, 2016
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentDeborah A Marshall, Ken Deal, Yvonne Bombard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
HER-2 and topoisomerase II as predictors of response to chemotherapyKathleen I Pritchard, Hans Messersmith, Leela Elavathil, et al.
Cancer|August 20, 2009
Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node statusRebecca Dent, Wedad M Hanna, Maureen Trudeau, et al.
Breast Cancer Research and Treatment|July 20, 2007
HER2/neu in systemic therapy for women with breast cancer: a systematic reviewBindi Dhesy-Thind, Kathleen I Pritchard, Hans Messersmith, et al.
Breast Cancer Research and Treatment|June 11, 2008
Pattern of metastatic spread in triple-negative breast cancerRebecca Dent, Wedad M Hanna, Maureen Trudeau, et al.
Healthcare Quarterly (Toronto, Ont.)|June 24, 2014
Optimizing resource allocation and patient flow: process analysis and reorganization in three chemotherapy outpatient clinicsMorgan Holmes, Kelly Bodie, Geoffrey Porter, et al.
Journal of Oncology Practice|September 22, 2010
Safe handling of parenteral cytotoxics: recommendations for ontarioEsther Green, Mary Johnston, Maureen Trudeau, et al.
American Journal of Clinical Oncology|June 7, 2007
Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxaneSunil Verma, Nan Soon Wong, Maureen Trudeau, et al.
The Breast Journal|December 1, 2004
Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgeryKaren P L Yap, David R McCready, Anthony Fyles, et al.
Health Care Management Science|January 31, 2014
Dynamic optimization of chemotherapy outpatient scheduling with uncertaintyShoshana Hahn-Goldberg, Michael W Carter, J Christopher Beck, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
BMJ Open|June 4, 2016
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentDeborah A Marshall, Ken Deal, Yvonne Bombard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
HER-2 and topoisomerase II as predictors of response to chemotherapyKathleen I Pritchard, Hans Messersmith, Leela Elavathil, et al.
Cancer|August 20, 2009
Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node statusRebecca Dent, Wedad M Hanna, Maureen Trudeau, et al.
Breast Cancer Research and Treatment|July 20, 2007
HER2/neu in systemic therapy for women with breast cancer: a systematic reviewBindi Dhesy-Thind, Kathleen I Pritchard, Hans Messersmith, et al.
Breast Cancer Research and Treatment|June 11, 2008
Pattern of metastatic spread in triple-negative breast cancerRebecca Dent, Wedad M Hanna, Maureen Trudeau, et al.
Healthcare Quarterly (Toronto, Ont.)|June 24, 2014
Optimizing resource allocation and patient flow: process analysis and reorganization in three chemotherapy outpatient clinicsMorgan Holmes, Kelly Bodie, Geoffrey Porter, et al.
Journal of Oncology Practice|September 22, 2010
Safe handling of parenteral cytotoxics: recommendations for ontarioEsther Green, Mary Johnston, Maureen Trudeau, et al.
American Journal of Clinical Oncology|June 7, 2007
Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxaneSunil Verma, Nan Soon Wong, Maureen Trudeau, et al.
The Breast Journal|December 1, 2004
Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgeryKaren P L Yap, David R McCready, Anthony Fyles, et al.
Health Care Management Science|January 31, 2014
Dynamic optimization of chemotherapy outpatient scheduling with uncertaintyShoshana Hahn-Goldberg, Michael W Carter, J Christopher Beck, et al.
Pageof 11